CVS Health Corporation (CVS) Insider Trading

Last 12 months

Insiders sold $324M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Larry Robbins sold $317M on May 21, 41% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2025.

Net open-market

−$324M

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Jun 2025

Jun 5, 2025

Get an email when CVS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 19 – 21	Larry Robbins Director	SoldNo plan 7 parts	3,372,000	$94.15 average	$317M	41%	Form 4
May 8	Tilak Mandadi EVP, Chief Exp & Tech Officer	SoldNo plan	69,551	$89.58	$6.23M	87%	Form 4
Aug 20, 2025	Anne A. Finucane Director	SoldNo plan	7,500	$71.02	$533k	25%	Form 4
Jun 5, 2025	Guy P Sansone Director	Bought	1,570	$63.70	$100k	15%	Form 4
May 2, 2025 – May 6, 2025	Larry Robbins Director	SoldNo plan 6 parts	3,750,000	$67.66 average	$254M	31%	Form 4
Mar 5, 2025	James David Clark SVP, Cont & Chief Acct Officer	SoldNo plan	7,513	$66.35	$498k	47%	Form 4
Feb 18, 2025	Michael F Mahoney Director	Bought	30,000	$66.70	$2M	190%	Form 4
Jan 23, 2025	Steven H Nelson EVP and President, Aetna	Bought	24	$53.70	$1k	New	Form 4

May 19 – 21No plan
Larry Robbins
Director · sold 3,372,000 at avg $94.15
$317M
41% of stake
May 8No plan
Tilak Mandadi
EVP, Chief Exp & Tech Officer · sold 69,551 at $89.58
$6.23M
87% of stake
Aug 20, 2025No plan
Anne A. Finucane
Director · sold 7,500 at $71.02
$533k
25% of stake
Jun 5, 2025
Guy P Sansone
Director · bought 1,570 at $63.70
$100k
15% of stake
May 2, 2025 – May 6, 2025No plan
Larry Robbins
Director · sold 3,750,000 at avg $67.66
$254M
31% of stake
Mar 5, 2025No plan
James David Clark
SVP, Cont & Chief Acct Officer · sold 7,513 at $66.35
$498k
47% of stake
Feb 18, 2025
Michael F Mahoney
Director · bought 30,000 at $66.70
$2M
190% of stake
Jan 23, 2025
Steven H Nelson
EVP and President, Aetna · bought 24 at $53.70
$1k
New position

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CVS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Retail-Drug Stores and Proprietary Stores

AMZNAmazon.com, Inc.

Spot a number that looks wrong? Check it in CVS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CVS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.